Alerts will be sent to your verified email
Verify EmailASTONEALAB
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Astonea Labs specializes in the manufacturing and marketing of a wide range of pharmaceutical and cosmetic products. These include antibiotic drugs, anti-cold medications, antihistamines, and drugs for diabetes, cardiovascular diseases, gynecological concerns, analgesics, fungal infections, and multivitamins.
Astonea Labs major competitors are Beta Drugs.
Market Cap of Astonea Labs is ₹142 Crs.
While the median market cap of its peers are ₹1,850 Crs.
Astonea Labs seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
Earnings Release | ||||||||||||||||||
Investor Presentation | ||||||||||||||||||
Conference Call | ||||||||||||||||||
Conference Call SummaryCon Call Summary
Powered by Gemini
|